Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

Compliance with requirements for registration and reporting of results in trials of mesenchymal stromal cells for musculoskeletal disorders: a systematic review

Holtedahl R., Brox JI.

Systematic Review with a reported sample of 993 on Knee Osteoarthritis, Osteoarthritis, published in BMJ Open (2024) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
BMJ Open (2024)
Reported sample size
993
Source database
Europe PMC
PMID
38925685
PMCID
PMC11202644
DOI
10.1136/bmjopen-2023-081343

Abstract (original English)

Objective To assess compliance with statutory requirements to register and report outcomes in interventional trials of mesenchymal stromal cells (MSCs) for musculoskeletal disorders and to describe the trials' clinical and design characteristics. Design A systematic review of published trials and trials submitted to public registries. Data sources The databases Medline, Cochrane Library and McMaster; six public clinical registries. All searches were done until 31 January 2023. Eligibility criteria Trials submitted to registries and completed before January 2021. Prospective interventional trials published in peer-reviewed journals. Data extraction and synthesis The first author searched for trials that had (1) posted trial results in a public registry, (2) presented results in a peer-reviewed publication and (3) submitted a pretrial protocol to a registry before publication. Other extracted variables included trial design, number of participants, funding source, follow-up duration and cell type. Results In total 124 trials were found in registries and literature databases. Knee osteoarthritis was the most common indication. Of the 100 registry trials, 52 trials with in total 2 993 participants had neither posted results in the registry nor published results. Fifty-two of the registry trials submitted a protocol retrospectively. Forty-three of the 67 published trials (64%) had r

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
Mesenchymal Stem CellsHumansMusculoskeletal DiseasesMesenchymal Stem Cell TransplantationRegistriesResearch DesignGuideline AdherenceClinical Trials as Topic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research